• Users Online: 38
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2021  |  Volume : 10  |  Issue : 3  |  Page : 276-279

COVID-19 and lung cancer: Strengthening the prevention component and improving the prognosis


1 Department of Community Medicine, Medical Education Unit, Institute Research Council, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth – Deemed to be University, Chengalpattu, Tamil Nadu, India
2 Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth – Deemed to be University, Chengalpattu, Tamil Nadu, India

Correspondence Address:
Dr. Saurabh RamBihariLal Shrivastava
Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth (SBV) – Deemed to be University, Thiruporur - Guduvancherry Main Road, Ammapettai, Nellikuppam, Chengalpet District - 603108, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijrc.ijrc_2_21

Rights and Permissions

The coronavirus disease-2019 (COVID-19) pandemic overwhelmed health-care delivery systems owing to the significant morbidity and mortality. Lung cancer in the year 2020 alone has accounted for more than 2.2 million new cases and 1.8 million deaths across the globe. The purpose of the current review is to explore the impact of COVID-19 on lung cancer and to identify measures that can improve the prognosis of cancer patients during the ongoing COVID-19 pandemic. An extensive search related to the topic was carried out in the PubMed and World Health Organization website. Relevant research articles focusing on COVID-19 and lung cancer published between April 2020 and June 2021 were included in the review. Forty-five studies similar to the current study objectives were identified initially. Among them, five were excluded due to unavailability of the complete version of the articles. Overall, forty articles were selected based on the suitability with current review objectives. Keywords used in the search include COVID-19 and Lung cancer in the title alone only. It has been estimated that patients with lung cancer will have a significantly higher risk of an adverse outcome, if they acquire COVID-19 infection. National bodies across multiple nations have released recommendations for both prevention and optimal management of COVID-19 infection among known lung cancer patients. To conclude, the COVID-19 pandemic has significantly affected patients with lung cancer. Owing to the emergence of evidence of poor prognosis of infection among lung cancer patients, there is an indispensable need to adopt a multidisciplinary treatment approach.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed540    
    Printed6    
    Emailed0    
    PDF Downloaded65    
    Comments [Add]    

Recommend this journal